Ozempic, Wegovy and Mounjaro face US lawsuits over rare vision-loss risk

1 month ago

Dozens of people in the United States have sued the manufacturers of popular GLP-1 drugs, claiming that the medicines caused a rare eye condition that can result in permanent vision loss, according to US media reports.

Ozempic, Wegovy and Mounjaro face US lawsuits over rare vision-loss risk

Related News

CBD COP17: Namibian Biosafety Expert Martha Kandawa-Schulz d...

Brazil: long queues and river journeys mark decisive preside...

Thousands of sheep take over Madrid's streets for Transhuman...

Gabon restores social media access after an eight-month ban

Death toll in Taraba terror attack rises to 40

Saudi Arabia's Riyadh airport partially resumes flights afte...

Iranian president blames United States for failure of interi...

The city does not smell of roses, By Temitope Sodipo

Over 1,000 arrested in France after a day of mostly peaceful...

Red Cross trains staff as Kenya records its second death fro...

Niger imposes curfew on petrol sales amid national fuel shor...

Nigeria's Tinubu defends policies as he launches re-election...

Poison for profit: Why fake drinks are killing Nigerians and...

Haiti's ex-president Martelly registers as candidate for upc...

Ebola: Lagos is prepared to respond — Commissioner

HIV prevention jab offers hope in Uganda but doses are hard ...

Two 'unauthorised' oil tankers struck in Strait of Hormuz, I...

New Tumaini Ebola vaccine trial launches in Bunia as DRC str...

Brazil candidates make final campaign push ahead of presiden...

France-Nigeria business forum postponed after Macron cancels...

Popular News

How Katy Perry Ended Up in Teenage Dream Love With Justin Tr...

Man killed by falling tree as Storm Boelo brings more severe...

Brazil 2026 election live: Lula and Bolsonaro in tight race

Gunmen kill at least 10 people in eastern Nigeria, police sa...

Iran war live: Trump hints at possible Sunday Iran attack or...